New group program aims to boost quality of life for stem cell transplant survivors

NCT ID NCT06160986

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a group-based behavioral program called Horizons can improve quality of life and coping skills in adults with chronic graft-versus-host disease (cGVHD), a common complication after stem cell transplant. The program involves 8 weekly video sessions with a clinician and behavioral health specialist. The main goal is to see if the program is feasible—meaning enough people enroll, attend, and complete it—not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Horizons Group Intervention (behavioral program)

What this could lead to

If it works, this could provide a practical, group-based program to help people with chronic graft-versus-host disease better manage their symptoms and improve their quality of life.

What could go wrong

This is a very small, early feasibility study with only 20 participants, so results may not apply to everyone. The program is behavioral, not a medical treatment, so it won't cure the disease or replace standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic graft versus host disease disease related to hematopoietic stem cell transplant graft versus host disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Miami

    Miami, Florida, 33136, United States